ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maine » Internal Medicine

Top Internal Medicine Prescribers in Maine

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GENE CHENG MD

Internal Medicine

5,636

$457K

291
263 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$81
Average prescription price

Avg: $69

STEVEN DOBIESKI MD

Internal Medicine

5,630

$381K

388
342 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $69

ROBERT LAURENCE MD

Internal Medicine

5,593

$434K

322
292 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$78
Average prescription price

Avg: $69

AQUILINO ALAMO MD

Internal Medicine

5,582

$362K

416
359 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $69

STACY HERSHFELD D.O.

Internal Medicine

5,577

$482K

362
248 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$86
Average prescription price

Avg: $69

JAMES RINES MD

Internal Medicine

5,565

$319K

349
298 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $69

RICHARD KAPPELMANN MD

Internal Medicine

5,440

$395K

329
288 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$73
Average prescription price

Avg: $69

ERIC SCHENK D.O.

Internal Medicine

5,437

$391K

286
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$72
Average prescription price

Avg: $69

JODEE MOSHER M.D.

Internal Medicine

5,413

$268K

406
377 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

3%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $69

RICHARD KAHN M.D.

Internal Medicine

5,396

$269K

270
250 are 65+

22%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $69

CORNELIUS YETMAN D.O.

Internal Medicine

5,382

$338K

333
261 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $69

FREDERICK HEINEMAN MD

Internal Medicine

5,378

$239K

339
316 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $69

PETER EMERY MD

Internal Medicine

5,315

$380K

358
320 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$72
Average prescription price

Avg: $69

CHRISTINE HANDANOS MD

Internal Medicine

5,246

$388K

402
294 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $69

JAMES ZEITLIN MD

Internal Medicine

5,231

$436K

357
321 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $69

HARENDRA PATEL MD

Internal Medicine

5,177

$414K

249
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 24%

$80
Average prescription price

Avg: $69

ERIC MUKAI M.D.

Internal Medicine

5,131

$356K

451
346 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $69

DANIEL MERSON D.O

Internal Medicine

5,127

$359K

291
245 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $69

SUZANNE DATER MD

Internal Medicine

5,117

$376K

435
359 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $69

PATRICIA WYSHAK MD

Internal Medicine

5,106

$412K

292
228 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$81
Average prescription price

Avg: $69

GARY HATFIELD MD

Internal Medicine

5,101

$341K

268
234 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $69

NICHOLAS HANDANOS M.D.

Internal Medicine

5,099

$267K

413
284 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $69

DANIEL LOISELLE MD

Internal Medicine

5,063

$388K

313
266 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$77
Average prescription price

Avg: $69

DENISE ANDERSON D.O.

Internal Medicine

5,016

$310K

395
341 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $69

JOHN PARKER MD

Internal Medicine

5,003

$505K

348
276 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$101
Average prescription price

Avg: $69

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank